Status:
UNKNOWN
The Effect of Chloroquine in the Treatment of Patients With Dengue
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions:
Dengue
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The objective of this study was to evaluate the effect of chloroquine in the treatment of patients with dengue.
Eligibility Criteria
Inclusion
- Patients suspected of having dengue disease
- Patients were included in the study if they presented with fever and at least two other symptoms, such as:
- headache
- pain behind the eyes
- muscle and bone or joint pains
- nausea
- vomiting
- rash associated to dengue for less than 72 hours
Exclusion
- Pregnant
- Younger than 18-years old
- Either cardiac or neurologic disease
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT00849602
Start Date
February 1 2008
End Date
June 1 2009
Last Update
February 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
São Paulo University Medical School at Ribeirão Preto
Ribeirão Preto, São Paulo, Brazil, 14048.900